CLIA-certified, CAP-accredited CRO providing spatial biology and next-generation tissue pathology services (multiplex immunofluorescence, IHC, histology, digital pathology, dPCR/qPCR, NGS) for translational research and drug-development teams. Delivers end-to-end method development, validation, sample testing, regulatory compliance and clinical-trial logistics to enable biomarker discovery, tumor microenvironment mapping and patient stratification.